Expand CRNX Menu
CRNX MENU

CRNX Stock Posts


Upcoming Earnings

CRNX Crinetics Pharmaceuticals42.89-0.50 (-1.2%)

Crinetics Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±10.7% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±5.2%. View Expected Move (Conf Call: Feb 26 4:30 PM)
Unusual Option Volume

CRNX Crinetics Pharmaceuticals44.11+1.25 (+2.9%)

Crinetics Pharmaceuticals trades 2,689 contracts.
View Details...
Unusual Option Volume

CRNX Crinetics Pharmaceuticals42.72+1.29 (+3.1%)

Crinetics Pharmaceuticals trades 3,126 contracts.
View Details...
Upcoming Earnings

CRNX Crinetics Pharmaceuticals42.70+0.17 (+0.4%)

Crinetics Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±5.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±4.5%. View Expected Move (Conf Call: Nov 6 4:30 PM)
Unusual Option Volume

CRNX Crinetics Pharmaceuticals43.82-2.09 (-4.6%)

Crinetics Pharmaceuticals trades 2,621 contracts.
View Details...
Unusual Option Volume

CRNX Crinetics Pharmaceuticals44.36+8.47 (+23.6%)

Crinetics Pharmaceuticals trades 4,246 contracts. News: Crinetics Announces FDA Approval of PALSONIFY (paltusotine) for the Treatment of Adults with Acromegaly
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes